ARCHIVES

Genentech Reps Not Welcome: Hospitals Urge Drug Maker to Reverse Policy On Supplying Avastin, Rituxan, & Herceptin

This article is from The Cancer Letter archive.

Vol. 40 No. 39 | October 17, 2014

Download PDF Visit The Full Archive

Related Articles

House Passes 2.8 Percent Increase For NCI

December 11, 2009

Also M.D. Anderson awarded three new, one renewal SPORE grant.

October 31, 2003

Magnson Makes It Clear Senate Will Add Substantial Sums To Budget, Objects To Training Grant Phaseout

May 17, 1974

In Brief: No Decision Yet On How CALB Cuts Will Be Made; Wyngaarden Of Duke Will Be New Director of NIH

January 29, 1982

NCI Health Disparities Center Describes “Think Tank” Projects For Policy Change.

April 27, 2001

Alternating Mammography, MRI Tested For High-Risk Women

January 30, 2009